Skip to main content
. 2021 Aug 17;44(1):64–71. doi: 10.1007/s11096-021-01313-3

Table 1.

Characteristics of participants

IW-2017 (n = 62) IW-2019 (n = 52) p-value
Types of hospitals [number (%)] 0.463
 University hospital 34 (54.9%) 35 (67.3%)
 Maximum care hospitals 11 (17.7%) 7 (13.5%)
 Hospital of full medical care/specialist hospital 8 (12.9%) 3 (5.8%)
 General hospitals 9 (14.5%) 7 (13.5%)
Professional experience of participating pharmacists [Median (range), years]
 Hospital pharmacist 9 (1.5–35) 9.5 (0.5–32) 0.984
 Expert clinical pharmacist according to further training regulations 3 (0–30) 1.5 (0–25) 0.241
 Clinical pharmaceutical services 6 (0.5–34) 6 (1–19) 0.451
Frequency of clinical pharmaceutical services [number (%)] 0.022
 Daily 37 (59.7%) 43 (82.7%)
 2–3-times per week 14 (22.6%) 2 (3.8%)
 Once weekly 10 (16.1%) 6 (11.5%)
 Less than once weekly 1 (1.6%) 1 (1.9%)
Patient days per week [Median (IQR; range)] 97 (40–211; 4–1000) 85 (30–158; 2–1500) 0.444
Frequency of the use of ADKA DokuPIK [number] 0.499
 Daily 2 (3.2%) 3 (5.8%)
 2–3 times per week 8 (12.9%) 4 (7.7%)
 Once weekly 8 (12.9%) 6 (11.5%)
 Less than once weekly 14 (22.6%) 7 (13.5%)
 In the context of projects 30 (48.4%) 32 (61.5%)

Patient days are defined as the sum of all patients seen by the CP during a period of five working days

IQR inter-quartile range